ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,539,293, issued on Feb. 3, was assigned to Lumos Pharma Inc..
"Detecting and treating growth hormone deficiency" was invented by Michael Oliver Thorner (Charlottesville, Va.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein is a new oral method for using MK-0677 for detecting growth hormone (GH) deficiency (GHD). Also described is a method of treating growth hormone (GH) deficiency (MD) in children with a functional hypothalamic-pituitary GH axis."
The patent was filed on Jan. 24, 2022, under Application No. 17/582,117.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?S...